...
首页> 外文期刊>European Journal of Pharmacology: An International Journal >MAGUK proteins: New targets for pharmacological intervention in the glutamatergic synapse.
【24h】

MAGUK proteins: New targets for pharmacological intervention in the glutamatergic synapse.

机译:MAGUK蛋白:谷氨酸能突触的药理干预新靶标。

获取原文
获取原文并翻译 | 示例
           

摘要

In the postsynaptic density of excitatory glutamatergic synapses, membrane associated guanylate kinase (MAGUK) proteins, such as Post-Synaptic Density 95 (PSD-95), organize ionotropic glutamate receptors and their associated signalling proteins regulating the strength of synaptic activity. Modifications of MAGUK proteins function in the glutamatergic synapse such as alterations of MAGUK proteins interaction with N-Methyl-D-Aspartate (NMDA) receptors regulatory subunits are common events in several neurodegenerative disorders. Thus, a better knowledge and understanding of MAGUK structure and function as well as of the molecular events regulating MAGUK-mediated interactions in the glutamatergic synapse could lead to the identification of new targets for pharmaceutical intervention for neurodegenerative diseases.
机译:在兴奋性谷氨酸能突触的突触后密度中,膜相关鸟苷酸激酶(MAGUK)蛋白(如突触后密度95(PSD-95))组织离子型谷氨酸受体及其相关信号蛋白,调节突触活性的强度。 MAGUK蛋白的修饰在谷氨酸能突触中起作用,例如MAGUK蛋白与N-甲基-D-天冬氨酸(NMDA)受体调节亚基相互作用的改变是几种神经退行性疾病中的常见事件。因此,对MAGUK的结构和功能以及调节谷氨酸能突触中MAGUK介导的相互作用的分子事件的更好的了解和理解可能会导致确定用于神经退行性疾病的药物干预的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号